![Austedo for Huntington's disease: Teva Pharmaceuticals has found a nifty way to keep drugs in your body for longer — Quartz Austedo for Huntington's disease: Teva Pharmaceuticals has found a nifty way to keep drugs in your body for longer — Quartz](https://cms.qz.com/wp-content/uploads/2017/04/rtx15k2q.jpg?quality=75&strip=all&w=410&h=231)
Austedo for Huntington's disease: Teva Pharmaceuticals has found a nifty way to keep drugs in your body for longer — Quartz
![Austedo (deutetrabenazine) for the Treatment of Chorea Associated with Huntington's Disease - Clinical Trials Arena Austedo (deutetrabenazine) for the Treatment of Chorea Associated with Huntington's Disease - Clinical Trials Arena](https://www.drugdevelopment-technology.com/wp-content/uploads/static-progressive/nri/drugdev/Projects/Teva/Austedo.jpg)
Austedo (deutetrabenazine) for the Treatment of Chorea Associated with Huntington's Disease - Clinical Trials Arena
![China Approves AUSTEDO® For Treating Chorea Associated with Huntington's Disease and Tardive Dyskinesia in Adults | Business Wire China Approves AUSTEDO® For Treating Chorea Associated with Huntington's Disease and Tardive Dyskinesia in Adults | Business Wire](https://mms.businesswire.com/media/20200518005219/en/739014/22/teva_RGB_JPEG.jpg)
China Approves AUSTEDO® For Treating Chorea Associated with Huntington's Disease and Tardive Dyskinesia in Adults | Business Wire
![Teva announces FDA approval of Austedo tablets for chorea associated with huntington's disease - Pharma Advancement Teva announces FDA approval of Austedo tablets for chorea associated with huntington's disease - Pharma Advancement](https://www.pharmaadvancement.com/wp-content/uploads/2017/04/teva_pharma.jpg)
Teva announces FDA approval of Austedo tablets for chorea associated with huntington's disease - Pharma Advancement
Teva Announces Post Hoc Analysis of Long-Term Data Examining Treatment with AUSTEDO® (deutetrabenazine) Tablets in Adult Patients with Tardive Dyskinesia
![Teva's Austedo (deutetrabenazine) Receives the NMPA's Approval to Treat Chorea Associated with Huntington's Disease and Tardive Dyskinesia in Adults Teva's Austedo (deutetrabenazine) Receives the NMPA's Approval to Treat Chorea Associated with Huntington's Disease and Tardive Dyskinesia in Adults](https://pharmashots.com/public/images/20211116004657_ogImage_28.jpg)